Champions Oncology and Medicines Discovery Catapult partner to accelerate radiopharmaceutical therapy development.
Champions Oncology and Medicines Discovery Catapult join forces to expedite radiopharmaceutical therapeutics development. This strategic partnership leverages Champions Oncology's PDX models and pharmacology solutions with MDC's radio-conjugates, radiochemistry, and advanced imaging expertise. The combined capabilities aim to advance targeted radionuclide therapies for cancer patients.
June 04, 2024
4 Articles